Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1604)
  2. Meeting Abstract (791)
  3. Book Section (104)
  4. Review (72)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1690)
  2. Survivorship Research (1193)
  3. Solid Tumor Oncology Division (1052)
  4. Department of Pathology and Laboratory Medicine (957)
  5. Surgery (947)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (698)
  2. Daniel Coit (543)
  3. Allan Halpern (401)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (89)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (84)
  5. Modern Pathology (67)
  6. American Journal of Surgical Pathology (64)

More Publications

Publishers
  1. Springer (341)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (162)
  6. Elsevier Science, Inc. (160)

More Publishers

Results (2770)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade
    Journal Article

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K. S.; Hayes, S. A.; Bajwa, R.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Interpretation of the complex melanoma pathology report
    Review

    Crompton, J. G.; Busam, K. J.; Bartlett, E. K.
    Surgical Oncology Clinics of North America (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Optimization of T-cell receptor-modified T cells for cancer therapy
    Journal Article

    Drakes, D. J.; Rafiq, S.; Purdon, T. J.; Lopez, A. V.; Chandran, S. S.; Klebanoff, C. A.; Brentjens, R. J.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry for PRAME with cytogenetic test results in the evaluation of challenging melanocytic tumors
    Journal Article

    Lezcano, C.; Jungbluth, A. A.; Busam, K. J.
    American Journal of Surgical Pathology (2020)

    Fulltext@MSK | Save
  • Quality of life concerns in patients with uveal melanoma after initial diagnosis
    Journal Article

    Barker, C. A.; Kozlova, A.; Shoushtari, A. N.; Hay, J. L.; Francis, J. H.; Abramson, D. H.
    Ocular Oncology and Pathology (2020)

    Fulltext@MSK | Save
  • Isolated abducens nerve palsy following pembrolizumab
    Journal Article

    Jaben, K. A.; Francis, J. H.; Shoushtari, A. N.; Abramson, D. H.
    Neuro-Ophthalmology (2020)

    Fulltext@MSK | Save
  • Facial erythema in an elderly man
    Miscellaneous

    Navarrete-Dechent, C.; Busam, K. J.; Markova, A.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Co-occurrence of Merkel cell carcinoma and chronic inflammatory demyelinating polyneuropathy
    Correspondence

    Kuo, A. M. S.; Barker, C. A.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • TNFα blockade in checkpoint inhibition: The good, the bad, or the ugly?
    Editorial

    Weber, J. S.; Postow, M. A.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save